Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -9.86%2.72B | -9.90%6.04B | -15.56%3.01B | -16.79%6.71B | -14.68%3.57B | 12.04%8.06B | 26.03%4.18B | 27.35%7.2B | 30.62%3.32B | 14.72%5.65B |
| Operating income | -9.86%2.72B | -9.90%6.04B | -15.56%3.01B | -16.79%6.71B | -14.68%3.57B | 12.04%8.06B | 26.03%4.18B | 27.35%7.2B | 30.62%3.32B | 14.72%5.65B |
| Cost of sales | 10.00%-1.44B | 14.10%-3.19B | 19.71%-1.6B | 21.89%-3.72B | 20.45%-2B | -8.88%-4.76B | -26.10%-2.51B | -31.86%-4.37B | -34.19%-1.99B | -11.15%-3.31B |
| Operating expenses | 10.00%-1.44B | 14.10%-3.19B | 19.71%-1.6B | 21.89%-3.72B | 20.45%-2B | -8.88%-4.76B | -26.10%-2.51B | -31.86%-4.37B | -34.19%-1.99B | -11.15%-3.31B |
| Gross profit | -9.70%1.27B | -4.70%2.85B | -10.29%1.41B | -9.44%2.99B | -6.01%1.57B | 16.94%3.31B | 25.93%1.67B | 20.96%2.83B | 25.59%1.33B | 20.18%2.34B |
| Selling expenses | 12.77%-302.66M | -14.52%-772.43M | 2.11%-346.98M | 17.91%-674.48M | 7.07%-354.45M | -14.71%-821.61M | -14.29%-381.42M | -43.44%-716.23M | -40.90%-333.73M | -7.23%-499.32M |
| Administrative expenses | 10.57%-515.82M | -12.51%-1.32B | 0.73%-576.8M | -4.50%-1.17B | -7.34%-581.02M | -16.99%-1.12B | -21.99%-541.28M | -22.62%-958.19M | -16.33%-443.71M | -5.11%-781.46M |
| Impairment and provision | -120.27%-2.76M | 582.54%6.96M | -31.97%13.62M | -146.68%-1.44M | 731.26%20.03M | 114.32%3.09M | 106.75%2.41M | 66.84%-21.58M | 16.93%-35.69M | 1.26%-65.08M |
| -Other impairment is provision | -120.27%-2.76M | 582.54%6.96M | -31.97%13.62M | -146.68%-1.44M | 731.26%20.03M | 114.32%3.09M | 106.75%2.41M | 66.84%-21.58M | 16.93%-35.69M | 1.26%-65.08M |
| Special items of operating profit | -48.76%19.7M | -19.97%86.23M | 12.76%38.44M | 71.74%107.75M | 13.23%34.09M | -57.26%62.74M | -61.83%30.11M | 93.83%146.77M | 91.62%78.87M | -17.54%75.72M |
| Operating profit | -12.38%471M | -31.75%856.16M | -22.05%537.53M | -12.24%1.25B | -11.72%689.57M | 11.84%1.43B | 31.74%781.1M | 19.75%1.28B | 35.79%592.9M | 40.12%1.07B |
| Financing cost | 15.89%-2.45M | -3.35%-5.56M | -19.92%-2.91M | 4.83%-5.38M | 22.08%-2.43M | 19.06%-5.65M | 11.79%-3.11M | 15.76%-6.98M | 7.79%-3.53M | -60.72%-8.29M |
| Special items of earning before tax | -155.51%-2.6M | 113.87%10.64M | 85.00%4.69M | -32.92%4.97M | 13.74%2.53M | 114.68%7.42M | 145.26%2.23M | 157.13%3.45M | 124.65%908K | -236.26%-6.05M |
| Earning before tax | -13.60%465.95M | -31.32%861.25M | -21.80%539.3M | -12.38%1.25B | -11.60%689.67M | 12.29%1.43B | 32.18%780.21M | 21.05%1.27B | 37.56%590.28M | 39.51%1.05B |
| Tax | 6.22%-74.6M | -57.91%-140.32M | -164.62%-79.54M | 45.45%-88.86M | 60.67%-30.06M | 10.59%-162.91M | -6.66%-76.43M | -22.29%-182.21M | -66.07%-71.66M | -14.78%-148.99M |
| After-tax profit from continuing operations | -14.88%391.35M | -38.12%720.92M | -30.30%459.76M | -8.13%1.17B | -6.28%659.61M | 16.11%1.27B | 35.70%703.79M | 20.84%1.09B | 34.37%518.63M | 44.65%903.85M |
| Earning after tax | -14.88%391.35M | -38.12%720.92M | -30.30%459.76M | -8.13%1.17B | -6.28%659.61M | 16.11%1.27B | 35.70%703.79M | 20.84%1.09B | 34.37%518.63M | 44.65%903.85M |
| Minority profit | -90.84%474K | -24.59%7.5M | -42.29%5.18M | 181.72%9.94M | 123.38%8.97M | -58.34%3.53M | 11.37%4.02M | 127.21%8.47M | 93.66%3.61M | 276.08%3.73M |
| Profit attributable to shareholders | -14.01%390.88M | -38.24%713.43M | -30.13%454.58M | -8.66%1.16B | -7.02%650.64M | 16.69%1.26B | 35.87%699.77M | 20.40%1.08B | 34.08%515.02M | 44.28%900.12M |
| Basic earnings per share | -13.18%0.369 | -37.77%0.669 | -29.52%0.425 | -8.12%1.075 | -6.66%0.603 | 18.30%1.17 | 37.45%0.646 | 19.44%0.989 | 33.14%0.47 | 46.03%0.828 |
| Diluted earnings per share | -12.74%0.363 | -37.39%0.658 | -29.37%0.416 | -7.89%1.051 | -6.66%0.589 | 19.23%1.141 | 38.68%0.631 | 16.28%0.957 | 28.90%0.455 | 45.15%0.823 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.